Lexology January 20, 2026
Hall Render Killian Heath & Lyman PC

The health care transactional landscape may have been quieter than anticipated at the beginning of 2025, with providers experiencing financial strains, but the year finished out with a high level of activity, marked by opportunistic growth strategies. Transactions will continue to be anything but “cookie-cutter.” In this article, we highlight eight M&A trends demonstrating how the financial landscape, regulatory considerations, cross-disciplinary strategies and market disruptors shaped deals in 2025 and how these same factors will continue to impact deals in 2026.

1. Non-Core Asset Carveouts

Over the past year, we saw growth in strategic divestitures involving non-core assets. One area contributing to this momentum relates to the proliferation in the sale of outreach laboratory testing businesses by health care systems....

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Provider, Trends
Healthcare & Life Sciences Private Equity Deal Tracker: Water Street Acquires Pillr From Renovus
Mirum Pharmaceuticals Completes $268.6 Million Acquisition of Bluejay Therapeutics to Strengthen Rare Disease Pipeline
Worldwide Clinical Trials to Buy Catalyst, Another M&A Deal Between Private Equity-Backed CROs
Consolidation trends in the medical device industry in 2026
Skilled Nursing Dealbook: PACS Expands With Acquisitions of 3 Post-Acute Operations and 4 Facility Properties

Share Article